SCHEMBL572968

SCHEMBL572968

CCCCCC(=O)CC(=O)CC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 1/20 0.59
KMT2A Q03164 2/20 0.54
MAPT P10636 1/20 0.54
CES2 O00748 4/20 0.52
CES1 P23141 4/20 0.52
AKR1B1 P15121 1/20 0.50
HSP90AA1 P07900 1/20 0.48
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5271811 0.98 HAO1 (0.63) HAO1KMT2AMAPTCES2CES1
SCHEMBL30690280 0.98 HAO1 (0.63) HAO1KMT2AMAPTCES2CES1
SCHEMBL8132087 0.98 HAO1 (0.63) HAO1KMT2AMAPTCES2CES1
SCHEMBL8111017 0.98 HAO1 (0.63) HAO1KMT2AMAPTCES2CES1
SCHEMBL17919122 0.98 HAO1 (0.63) HAO1KMT2AMAPTCES2CES1
Bromide SCHEMBL31482536 0.98 HAO1 (0.57) HAO1KMT2AMAPTCES2CES1
SCHEMBL949144 0.92 CES1 (0.50) HAO1KMT2AMAPTCES2CES1
SCHEMBL250549 0.92 HAO1 (0.67) HAO1KMT2AMAPTCES2CES1
Fluoride SCHEMBL27685331 0.90 HAO1 (0.48) HAO1KMT2AMAPTCES2CES1
SCHEMBL23437862 0.90 HAO1 (0.71) HAO1KMT2AMAPTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4117451-A1 PROCESS FOR PRODUCING AN AROMA-LADEN GAS, AROMA-LADEN GAS AND USE OF THE AROMA-LADEN GAS Döhler GmbH (DE) 2023-01-18 EP claimed
WO-2021185687-A1 PROCESS FOR PRODUCING AN AROMA-LADEN GAS, AROMA-LADEN GAS AND USE OF THE AROMA-LADEN GAS DÖHLER GmbH (DE) 2021-09-23 WO claimed
CN-111072482-A Photoresist resin monomer synthesized from spiro [2.5] decane-6, 8-dione and synthesis method thereof 上海博栋化学科技有限公司 2020-04-28 CN claimed
CN-110845987-A High-performance copolyamide hot melt adhesive composition 南通协鑫热熔胶有限公司 2020-02-28 CN claimed
EP-2601187-A1 DEUTERATED TANDOSPIRONE DERIVATIVES AS 5-HT1A RECEPTOR AGONISTS Conrig Pharma ApS (DK) 2013-06-12 EP claimed
WO-2013001498-A1 AMIDOALKYLPIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES ADAMED SP. Z O.O. (PL) 2013-01-03 WO claimed
WO-2012016569-A1 DEUTERATED TANDOSPIRONE DERIVATIVES AS 5-HT1A RECEPTOR AGONISTS CONRIG PHARMA APS (DK) 2012-02-09 WO claimed
US-20030092599-A1 Fragrance and flavor compositions and fragrance- and flavor-added products TAKASAGO INTERNATIONAL CORPORATION 2003-05-15 US claimed
EP-0912467-B1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE SA (FR) 2002-04-24 EP claimed
EP-0912467-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1999-05-06 EP claimed
WO-1998000375-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1998-01-08 WO claimed
US-20250243147-A1 ALICYCLIC ALIPHATIC 1,3-DICARBONYL DERIVATIVES USEFUL AS FRAGRANCES GIVAUDAN SA (CH) 2025-07-31 US disclosed
WO-2025105486-A1 ANTIBODY-PHOTOSENSITIVE SUBSTANCE CONJUGATE 第一三共株式会社 2025-05-22 WO disclosed
CN-118660885-A Norbornene analogs and their use as potentiators of antitubercular drugs 国家医疗保健研究所 2024-09-17 CN disclosed
EP-4423054-A1 ALICYCLIC ALIPHATIC 1,3-DICARBONYL DERIVATIVES USEFUL AS FRAGRANCES Givaudan SA (CH) 2024-09-04 EP disclosed
EP-0150710-A2 7-Oxabicycloheptane prostaglandin analogs E.R. Squibb & Sons, Inc. (US) 1985-08-07 EP disclosed
US-4533673-A 7-Oxabicycloheptane substituted enaminone prostaglandin analogs and their use in treatment of thrombolytic disease E. R. SQUIBB & SONS, INC. (US) 1985-08-06 US disclosed
EP-0124089-A1 Novel 5-acyl-2-(1H)-pyridinones MERRELL DOW PHARMACEUTICALS INC. (US) 1984-11-07 EP disclosed
US-4224218-A Stabilized vinyl chloride polymer comprising a metal mono-organic phosphite ARGUS CHEMICAL CORPORATION (US) 1980-09-23 US disclosed
US-4051229-A REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST THE JAPAN CARLIT CO., LTD. (JA) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092599-A1 Fragrance and flavor compositions and fragrance- and flavor-added products FAAH, KISS1R, DOHH HAO1 1876/4885KMT2A 515/4885MAPT 3002/4885
US-20250243147-A1 ALICYCLIC ALIPHATIC 1,3-DICARBONYL DERIVATIVES USEFUL AS FRAGRANCES MSI2, MLYCD, MCCC2 HAO1 2194/4885KMT2A 2479/4885MAPT 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.